Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 7 7 2020
medline: 2 9 2020
entrez: 7 7 2020
Statut: ppublish

Résumé

The dynamics of viral load (VL) of the severe acute respiratory syndrome coronavirus 2 and its association with different clinical parameters remain poorly characterized in the US patient population. Herein, we investigate associations between VL and parameters, such as severity of symptoms, disposition (admission versus direct discharge), length of hospitalization, admission to the intensive care unit, length of oxygen support, and overall survival in 205 patients from a tertiary care center in New York City. VL was determined using quantitative PCR and log10 transformed for normalization. Associations were tested with univariate and multivariate regression models. Diagnostic VL was significantly lower in hospitalized patients than in patients not hospitalized (log10 VL = 3.3 versus 4.0; P = 0.018) after adjusting for age, sex, race, body mass index, and comorbidities. Higher VL was associated with shorter duration of the symptoms in all patients and hospitalized patients only and shorter hospital stay (coefficient = -2.02, -2.61, and -2.18; P < 0.001, P = 0.002, and P = 0.013, respectively). No significant association was noted between VL, admission to intensive care unit, length of oxygen support, and overall survival. Our findings suggest a higher shedding risk in less symptomatic patients, an important consideration for containment strategies. Furthermore, we identify a novel association between VL and history of cancer. Larger studies are warranted to validate our findings.

Identifiants

pubmed: 32628931
pii: S0002-9440(20)30328-X
doi: 10.1016/j.ajpath.2020.07.001
pmc: PMC7332909
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1881-1887

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Science. 2003 Jun 20;300(5627):1961-6
pubmed: 12766206
J Transl Med. 2020 Jun 1;18(1):219
pubmed: 32487093
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Infect. 2020 May;80(5):e1-e6
pubmed: 32171869
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Clin Immunol. 2020 Jun;215:108448
pubmed: 32353634

Auteurs

Kimon V Argyropoulos (KV)

Department of Pathology, NYU Langone Health, New York, New York.

Antonio Serrano (A)

Department of Pathology, NYU Langone Health, New York, New York.

Jiyuan Hu (J)

Department of Population Health, NYU Grossman School of Medicine, New York, New York.

Margaret Black (M)

Department of Pathology, NYU Langone Health, New York, New York.

Xiaojun Feng (X)

Department of Pathology, NYU Langone Health, New York, New York.

Guomiao Shen (G)

Department of Pathology, NYU Langone Health, New York, New York.

Melissa Call (M)

Interdisciplinary Melanoma Program, New York University School of Medicine, New York, New York.

Min J Kim (MJ)

Interdisciplinary Melanoma Program, New York University School of Medicine, New York, New York.

Andrew Lytle (A)

Department of Pathology, NYU Langone Health, New York, New York.

Brendan Belovarac (B)

Department of Pathology, NYU Langone Health, New York, New York.

Theodore Vougiouklakis (T)

Department of Pathology, NYU Langone Health, New York, New York.

Lawrence H Lin (LH)

Department of Pathology, NYU Langone Health, New York, New York.

Una Moran (U)

Interdisciplinary Melanoma Program, New York University School of Medicine, New York, New York; Center for Biospecimen Research and Development, NYU Langone Health, New York, New York.

Adriana Heguy (A)

Department of Pathology, NYU Langone Health, New York, New York.

Andrea Troxel (A)

Department of Population Health, NYU Grossman School of Medicine, New York, New York.

Matija Snuderl (M)

Department of Pathology, NYU Langone Health, New York, New York.

Iman Osman (I)

Interdisciplinary Melanoma Program, New York University School of Medicine, New York, New York; Center for Biospecimen Research and Development, NYU Langone Health, New York, New York; Department of Dermatology, NYU Langone Health, New York, New York.

Paolo Cotzia (P)

Department of Pathology, NYU Langone Health, New York, New York; Center for Biospecimen Research and Development, NYU Langone Health, New York, New York. Electronic address: paolo.cotzia@nyulangone.org.

George Jour (G)

Department of Pathology, NYU Langone Health, New York, New York; Department of Dermatology, NYU Langone Health, New York, New York. Electronic address: george.jour@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH